Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis

NCT00802815 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Inclusion Body Myositis

Interventions

DRUG: Etanercept

Sponsor

Washington University School of Medicine

Collaborators

[object Object]